Polyarthritis resistant to anti-TNFs: clarification of the choice of 2nd line treatment
The choice of 2nd line biotherapy is now specified by a study which shows the superiority over 2 years of ...
Read moreTag: biotherapy
Lupus: targeted treatment shows great promise and is already available
For the first time in systemic lupus erythematosus, ustekinumab, an interleukin 13/23 inhibitor already available in other diseases, demonstrates its ...
Read more
Psoriasis: patients suffer from preconceived ideas
According to a survey conducted by pharmacists among 25,000 people with psoriasis, 29% of them do not follow any treatment. ...
Read more